CCR2 Composition for preventing or treating bone diseases comprising CCR2

The present invention relates to a pharmaceutical composition for preventing or treating bone diseases, containing a C-C chemokine receptor type 2 (CCR2) protein or a polynucleotide encoding the CCR2 protein as an active component, which can be usefully used for preventing or treating bone diseases...

Full description

Saved in:
Bibliographic Details
Main Authors NA HYUN SIK, CHOI JEONG WON, KIM SEOK JUNG, KIM GOO YOUNG, KIM SEON AE, LEE SEON YEONG, KWUAN JI YE, GO EUN JEONG, CHO KEUN HYUNG, CHOI SI YEONG, CHO MI LA, BAEK JIN AH
Format Patent
LanguageEnglish
Korean
Published 27.11.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a pharmaceutical composition for preventing or treating bone diseases, containing a C-C chemokine receptor type 2 (CCR2) protein or a polynucleotide encoding the CCR2 protein as an active component, which can be usefully used for preventing or treating bone diseases such as osteoarthritis. 본 발명은 CCR2(C-C chemokine receptor type 2) 단백질 또는 CCR2 단백질을 암호화하는 폴리뉴클레오타이드를 유효성분으로 포함하는 골질환의 예방 또는 치료용 약학적 조성물에 관한 것으로서, 골관절염과 같은 골질환의 예방 또는 치료에 유용하게 사용될 수 있다.
Bibliography:Application Number: KR20180057097